Alphamab Oncology (HKG:9966)
9.89
+0.46 (4.88%)
Jan 21, 2026, 4:08 PM HKT
211.01% (1Y)
| Market Cap | 9.13B |
| Revenue (ttm) | 861.24M |
| Net Income (ttm) | 255.11M |
| Shares Out | 968.57M |
| EPS (ttm) | 0.26 |
| PE Ratio | 36.42 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,908,000 |
| Average Volume | 1,770,221 |
| Open | 9.68 |
| Previous Close | 9.43 |
| Day's Range | 9.30 - 9.93 |
| 52-Week Range | 3.05 - 15.75 |
| Beta | 0.49 |
| RSI | 37.87 |
| Earnings Date | Mar 27, 2026 |